NPI: 1134426810 · BIRMINGHAM, AL 35233 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/16/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/16/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,707 | $277K |
| 2019 | 16,801 | $241K |
| 2020 | 17,714 | $194K |
| 2021 | 14,879 | $130K |
| 2022 | 10,167 | $189K |
| 2023 | 3,808 | $109K |
| 2024 | 2,361 | $48K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 26,737 | 1,917 | $729K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 27,496 | 1,392 | $394K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 565 | 227 | $31K |
| 83970 | 1,281 | 977 | $14K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 17,118 | 1,258 | $4K |
| 82108 | 563 | 422 | $4K | |
| 82728 | 1,579 | 1,217 | $3K | |
| 83550 | 1,381 | 1,038 | $3K | |
| A4657 | Syringe, with or without needle, each | 1,538 | 1,259 | $2K |
| 83540 | 1,561 | 1,196 | $2K | |
| 85045 | 1,348 | 1,088 | $1K | |
| J1756 | Injection, iron sucrose, 1 mg | 209 | 37 | $920.00 |
| 85041 | 992 | 819 | $640.77 | |
| 85048 | 992 | 819 | $596.25 | |
| 82746 | 20 | 13 | $57.84 | |
| 90674 | 17 | 17 | $56.26 | |
| 82947 | 79 | 43 | $46.50 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 18 | 12 | $26.94 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 923 | 532 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 20 | 20 | $0.00 |